
Jean P. Cornet
Examiner (ID: 15666, Phone: (571)270-7669 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1614, 1628 |
| Total Applications | 1519 |
| Issued Applications | 572 |
| Pending Applications | 146 |
| Abandoned Applications | 824 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10820408
[patent_doc_number] => 20160166573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF HYPERURICEMIA RELATED HEALTH CONSEQUENCES'
[patent_app_type] => utility
[patent_app_number] => 14/880412
[patent_app_country] => US
[patent_app_date] => 2015-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14735
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14880412
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/880412 | COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF HYPERURICEMIA RELATED HEALTH CONSEQUENCES | Oct 11, 2015 | Abandoned |
Array
(
[id] => 10685713
[patent_doc_number] => 20160031858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'DICARBOXYLIC ACID BISAMIDE DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS FOR PRODUCING DICARBOXYLIC ACID BISAMIDE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/879648
[patent_app_country] => US
[patent_app_date] => 2015-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10062
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14879648
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/879648 | DICARBOXYLIC ACID BISAMIDE DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS FOR PRODUCING DICARBOXYLIC ACID BISAMIDE DERIVATIVES | Oct 8, 2015 | Abandoned |
Array
(
[id] => 11934394
[patent_doc_number] => 20170238543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'AN ALDEHYDE CONTAINING COMPOSITION FOR INSECT CONTROL'
[patent_app_type] => utility
[patent_app_number] => 15/516725
[patent_app_country] => US
[patent_app_date] => 2015-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7553
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15516725
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/516725 | AN ALDEHYDE CONTAINING COMPOSITION FOR INSECT CONTROL | Oct 1, 2015 | Abandoned |
Array
(
[id] => 11934394
[patent_doc_number] => 20170238543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'AN ALDEHYDE CONTAINING COMPOSITION FOR INSECT CONTROL'
[patent_app_type] => utility
[patent_app_number] => 15/516725
[patent_app_country] => US
[patent_app_date] => 2015-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7553
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15516725
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/516725 | AN ALDEHYDE CONTAINING COMPOSITION FOR INSECT CONTROL | Oct 1, 2015 | Abandoned |
Array
(
[id] => 10676512
[patent_doc_number] => 20160022657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'BENZODIOXOLE OR BENZODIOXEPINE HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/872487
[patent_app_country] => US
[patent_app_date] => 2015-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10340
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872487
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/872487 | Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors | Sep 30, 2015 | Issued |
Array
(
[id] => 11935101
[patent_doc_number] => 20170239249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'QUINAZOLINE-BASED KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/514728
[patent_app_country] => US
[patent_app_date] => 2015-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70307
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15514728
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/514728 | QUINAZOLINE-BASED KINASE INHIBITORS | Sep 24, 2015 | Abandoned |
Array
(
[id] => 10662224
[patent_doc_number] => 20160008368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'Combination'
[patent_app_type] => utility
[patent_app_number] => 14/863709
[patent_app_country] => US
[patent_app_date] => 2015-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22356
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14863709
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/863709 | Combination | Sep 23, 2015 | Abandoned |
Array
(
[id] => 10662326
[patent_doc_number] => 20160008470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'STORAGE-STABLE COMPOSITIONS OF GLYCEROL MONOALKYL ETHERS'
[patent_app_type] => utility
[patent_app_number] => 14/862939
[patent_app_country] => US
[patent_app_date] => 2015-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6094
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14862939
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/862939 | STORAGE-STABLE COMPOSITIONS OF GLYCEROL MONOALKYL ETHERS | Sep 22, 2015 | Abandoned |
Array
(
[id] => 11225271
[patent_doc_number] => 09452985
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'Tau imaging probe'
[patent_app_type] => utility
[patent_app_number] => 14/860823
[patent_app_country] => US
[patent_app_date] => 2015-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 29
[patent_no_of_words] => 71803
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14860823
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/860823 | Tau imaging probe | Sep 21, 2015 | Issued |
Array
(
[id] => 11046179
[patent_doc_number] => 20160243137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'Anti-Inflammatory Compounds and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/858393
[patent_app_country] => US
[patent_app_date] => 2015-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17632
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14858393
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/858393 | Anti-Inflammatory Compounds and Use Thereof | Sep 17, 2015 | Abandoned |
Array
(
[id] => 10791524
[patent_doc_number] => 20160137679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'CARBON MONOXIDE RELEASING MOLECULES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/848047
[patent_app_country] => US
[patent_app_date] => 2015-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 37711
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14848047
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/848047 | CARBON MONOXIDE RELEASING MOLECULES AND USES THEREOF | Sep 7, 2015 | Abandoned |
Array
(
[id] => 10705402
[patent_doc_number] => 20160051549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3'
[patent_app_type] => utility
[patent_app_number] => 14/844041
[patent_app_country] => US
[patent_app_date] => 2015-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9236
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14844041
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/844041 | Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3 | Sep 2, 2015 | Issued |
Array
(
[id] => 10712575
[patent_doc_number] => 20160058722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'METHOD FOR IMPROVING THE OXYGEN-RELEASING ABILITY OF HEMOGLOBIN TO ORGANS AND PERIPHERAL TISSUES IN HUMAN BODIES'
[patent_app_type] => utility
[patent_app_number] => 14/840548
[patent_app_country] => US
[patent_app_date] => 2015-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1897
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14840548
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/840548 | METHOD FOR IMPROVING THE OXYGEN-RELEASING ABILITY OF HEMOGLOBIN TO ORGANS AND PERIPHERAL TISSUES IN HUMAN BODIES | Aug 30, 2015 | Abandoned |
Array
(
[id] => 12143699
[patent_doc_number] => 09877935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-30
[patent_title] => 'Parenteral dosage form of norepinephrine'
[patent_app_type] => utility
[patent_app_number] => 14/837749
[patent_app_country] => US
[patent_app_date] => 2015-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7648
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14837749
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/837749 | Parenteral dosage form of norepinephrine | Aug 26, 2015 | Issued |
Array
(
[id] => 13248923
[patent_doc_number] => 10137133
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Methods for treatment of diseases
[patent_app_type] => utility
[patent_app_number] => 14/837831
[patent_app_country] => US
[patent_app_date] => 2015-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 37643
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14837831
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/837831 | Methods for treatment of diseases | Aug 26, 2015 | Issued |
Array
(
[id] => 11038739
[patent_doc_number] => 20160235695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'COMBINATION COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/832154
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1625
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14832154
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/832154 | COMBINATION COMPOSITION | Aug 20, 2015 | Abandoned |
Array
(
[id] => 11611441
[patent_doc_number] => 09649284
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-16
[patent_title] => 'Treating critically ill patients with intravenous ibuprofen'
[patent_app_type] => utility
[patent_app_number] => 14/825803
[patent_app_country] => US
[patent_app_date] => 2015-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6557
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14825803
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/825803 | Treating critically ill patients with intravenous ibuprofen | Aug 12, 2015 | Issued |
Array
(
[id] => 11749298
[patent_doc_number] => 09707296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 14/825036
[patent_app_country] => US
[patent_app_date] => 2015-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7390
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14825036
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/825036 | Pharmaceutical composition | Aug 11, 2015 | Issued |
Array
(
[id] => 10450532
[patent_doc_number] => 20150335546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE'
[patent_app_type] => utility
[patent_app_number] => 14/819859
[patent_app_country] => US
[patent_app_date] => 2015-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4954
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14819859
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/819859 | Nitrone compounds and their use in personal care | Aug 5, 2015 | Issued |
Array
(
[id] => 10443135
[patent_doc_number] => 20150328146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'METHODS FOR ADMINISTRATION AND FORMULATIONS FOR THE TREATMENT OF REGIONAL ADIPOSE TISSUE'
[patent_app_type] => utility
[patent_app_number] => 14/812993
[patent_app_country] => US
[patent_app_date] => 2015-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 33097
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14812993
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/812993 | Methods for administration and formulations for the treatment of regional adipose tissue | Jul 28, 2015 | Issued |